关注
Tianyu Bai
Tianyu Bai
在 fda.hhs.gov 的电子邮件经过验证
标题
引用次数
引用次数
年份
Design optimization of a simple step-stress accelerated life test–Contrast between continuous and interval inspections with non-uniform step durations
D Han, T Bai
Reliability Engineering & System Safety 199, 106875, 2020
272020
Normalized power prior Bayesian analysis
K Ye, Z Han, Y Duan, T Bai
Journal of Statistical Planning and Inference 216, 29-50, 2022
232022
On the maximum likelihood estimation for progressively censored lifetimes from constant-stress and step-stress accelerated tests
D Han, T Bai
Electronic Journal of Applied Statistical Analysis 12 (2), 392-404, 2019
172019
Parameter estimation using EM algorithm for lifetimes from step-stress and constant-stress accelerated life tests with interval monitoring
D Han, T Bai
IEEE Transactions on reliability 70 (1), 49-64, 2019
162019
Optimal planning of progressively Type-I censored step-stress accelerated life test under interval inspection
D Han, T Bai
Communications in Statistics-Simulation and Computation 51 (12), 7565-7586, 2022
22022
Benefit-risk assessment for binary diagnostic tests
T Bai, L Huang, M Li, R Tiwari
Journal of Biopharmaceutical Statistics 29 (5), 760-775, 2019
12019
Exact inference for progressively Type-I censored step-stress accelerated life test under interval monitoring
D Han, T Bai
Computational Statistics, 1-29, 2022
2022
Bayesian approaches to benefit-risk assessment for diagnostic tests
T Bai, H Lan, R Tiwari
Journal of Biopharmaceutical Statistics 31 (4), 541-558, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–8